Aquaculture Breeding

" Single-use Bioprocessing Material Market  by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023 , " the global single-use bioprocessing material market was valued at $2,800.0 million in 2016, and is projected to reach $9,342.1 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023. The plastic segment accounted for five-eighths share of the global market in 2016.  Single-use bioprocessing technology has gained significant traction in the recent years, owing to the rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. This has fueled the manufacturers to integrate different materials in the construction of single-use bioprocessing products. These products have also proved beneficial for the small scale pharmaceutical manufacturers. Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components o

Human Growth Hormone Industry  was projected at $2.84 billion in 2018 and is anticipated to reach $5.56 billion by 2026, growing at a CAGR of 8.6% from 2019 to 2026. The report provides comprehensive analyses of the top investment pockets, key drivers & opportunities, major market segments, and competitive landscape.  Request Sample Report at  https://www.alliedmarketresearch.com/request-sample/6425 Increase in usage of growth hormone to control aging and surge in disorders related to growth hormone deficiency propel the growth of the global human growth hormone (hGH) market. On the other hand, several side effects related with the treatment impede the growth to some extent. However, rise in awareness toward usage of human growth hormone in developing economies is expected to offer multiple opportunities to the industry. Based on application, the turner syndrome segment held the major share in 2018, contributing nearly one-third of the global human growth hormone (hGH)

" Diabetes Therapeutics Market : Global Opportunity Analysis and Industry Forecast, 2017-2023," the global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. The major factor that contributes to the market growth are increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, development of affordable & effective diabetes therapeutics, rise in obese population, consumption of fast food, growth in awareness among people about self-management of diabetes, and support from the government further boost the market growth. However, side effects of diabetic drugs on patients and stringent approval process for these drugs hinder this growth. Moreover, rise in awareness about diabetes care and untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth. Read Mor

Allied Market Research published a report, titled,  " Biosensors Market  by Product (Wearable biosensors and Non- Wearable biosensors), Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, and Nanomechanical Biosensors): Global Opportunity Analysis and Industry Forecast, 2019–2026."  According to the report, the global biosensors market garnered $17.50 billion in 2018, and is estimated to reach $38.60 billion by 2026, registering a CAGR of 10.4% from 2019 to 2026.  Increase in chronic diseases such as diabetes, rise in R&D investments, and development of nanotechnology-based biosensors drive the growth of the global biosensors market. However, high cost associated with research and development (R&D) hinders the market growth. On the other hand, technological advancements in biosensors to make it user friendly are anticipated to offer new opportunities in the coming years. Read More@  https://www.prnewswire.com

Allied Market Research published a report, titled,  " Veterinary Infectious Disease Diagnostics Market , by Product Type (Immunodiagnostics, Molecular Diagnostics, and Others) and Application (Dogs, Cats, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026."  According to the report, the global veterinary infectious disease diagnostics industry garnered $1.27 billion in 2018, and is estimated to reach $2.40 billion by 2026, growing at a CAGR of 8.3% from 2019 to 2026  Increase in ownership of companion animals, surge in animal health expenditure, and demand for pet insurance drive the global veterinary infectious disease diagnostics market. However, lack of veterinary infrastructure in underdeveloped countries hinders the market growth. On the other hand, rise in awareness regarding animal healthcare across the world create new opportunities in coming years. Read More@  https://www.prnewswire.com/news-releases/veterinary-infectious-disease-diagnost